Anti-smoking drug can make people to contemplate suicide
Food and Drug Administration warned that anti-smoking drug Chantix (varenicline) isn’t as safety as it should be. Maybe smoking is dangerous, but Chantix can more seriously damage patient’s health.
According to the FDA Public Health Advisory, Pfizer Inc’s anti-smoking drug Chantix (varenicline) can cause behavioral changes, agitation, depression and the last but not the least, suicidal thoughts. This kind of reactions is more characteristic to persons with pre-existing psychiatric conditions.
It has been estimated that 39 individuals that used Chantix committed suicide. More dramatic is that more than 491 incidents of suicidal thoughts and behaviors were reported following the use of Chantix.
FDA officials asked company producer to introduce a new safety warning section for smokers to be aware of its potential neuropsychiatric effects.
Patients also ought to keep informed their doctors of previous psychiatric conditions before starting the drug.
FDA also asks families and doctors to monitor Chantix users and their changing behavior.
According to instruction, Chantix is believed to discourage smokers to light up and block nicotine effects in case user resumes this habit.
Taking into consideration negative effects of this anti-smoking drug Chantix, inevitably we ask ourselves: “Isn’t it better to enjoy a habit effects of which we know, but at least brings some pleasure, than to die from something that ought to cure?”
